Tailor treatment to the patient in stable angina

Practitioner

Volumn 255, Issue 1744, 2011, Pages 25-28

  Taggart, David ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VASODILATOR AGENT;

AGED; CONFERENCE PAPER; ELECTROCARDIOGRAPHY; FEMALE; HEALTH BEHAVIOR; HEART MUSCLE REVASCULARIZATION; HUMAN; LIFESTYLE; MALE; METHODOLOGY; MIDDLE AGED; STABLE ANGINA PECTORIS;

AGED; ANGINA, STABLE; ELECTROCARDIOGRAPHY; FEMALE; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; VASODILATOR AGENTS;

EID: 82455210723     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Health Survey for England 2006:CVD and risk factors adults, obesity and risk factors children. NHS Information Centre for Health and Social Care. 2008
2. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on myocardial revascularization. Euro Heart J 2010;31:2501-2555
3. National institute for Health and Clinical Excellence CG 126. Management of stable angina. NICE. London. 2011
4. Jeremias A, Kaul S, Rosengart TK et al. The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med 2009; 122:152-161
5. Yusuf S, Zucker D, Peduzzi P et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344:563-570 (Pubitemid 24267213)
6. Caracciolo EA, Davis KB, Sopko G et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience. Circulation 1995; 91:2335-2344
7. Brener SJ, Lytle BW, Casserly I et al. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 2004; 109:2290-2295 (Pubitemid 38678519)
8. Hannan EL, Racz MJ, Walford G et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005; 352:2174-2183
9. Hannan EL, Wu C, Walford G et al. Drug-eluting stents vs. Coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008;358:331-341 (Pubitemid 351159232)
10. Malenka DJ, Leavitt BJ, Hearne MI et al. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northen New England. Circulation2005; 112: 1371-1376
11. Smith PK, Califf RM, Tuttle RH et al. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. Ann Thorac Surg 2006; 82: 1420-1428
12. Dzavik V, Ghali WA, Norris C et al. Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: a report from the Alberta Provincial Project for outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Am Heart J2001; 142:119-126 (Pubitemid 32595383)
13. Davies RF, Goldberg AD, Forman S et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997; 95:2037-2043 (Pubitemid 27184271)
14. Shaw LJ, Berman DS, Maron DJ et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-1291 (Pubitemid 351365675)
15. Hachamovitch R, Hayes SW, Friedman JD et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography Circulation 2003;107:2900-2907
16. Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ 2000; 321:73-77 (Pubitemid 30438478)
17. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation 2005;111:2906-2912 (Pubitemid 40823048)
18. Hueb W, Lopes NH, Gersh B et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007; 115:1082-1089 (Pubitemid 46673170)
19. Schomig A, Mehilli J, de Waha A et al. A metaanalysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. J Am Coll Cardiol 2008; 52: 894-904
20. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A et al. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet 2009; 373:911-918
21. Boden WE, O'Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for stable coronary disease. N Eng J Med 2007; 356:1503-1516 (Pubitemid 46588415)
22. Aziz O, Rao C, Panesar SS et al. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaenous revascularisation for isolated lesions of the left anterior descending artery. BMJ 2007; 334:617
23. Kapoor JR, Gienger AL, Ardehali R et al. Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery. JACC Cardiovasc Interv 2008; 1:483-491
24. Serruys PW, Morice MC, Kappetein AP et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Eng J Med 2009; 360: 961-972